• Log in with Facebook Log in with Twitter Log In with Google      Sign In    
  • Create Account
  LongeCity
              Advocacy & Research for Unlimited Lifespans

Photo

Memogain®

alzheimers neuroprotection cognition prodrug galantamine

  • Please log in to reply
No replies to this topic

#1 Metagene

  • Guest
  • 674 posts
  • 78
  • Location:Florida
  • NO

Posted 26 October 2014 - 06:27 PM


Encouraging results from the Phase 1a clinical trial.

http://neurodyn-inc....eimers-disease/

Memogain (Gln-1062) is an inactive pro-drug of galantamine, the latter being a plant alkaloid approved for the treatment of mild to moderate Alzheimer's disease. Memogain has more than 15-fold higher bioavailability in the brain than the same doses of galantamine.



http://www.ncbi.nlm....ubmed/19669943/

Edited by Metagene, 26 October 2014 - 06:35 PM.




Also tagged with one or more of these keywords: alzheimers, neuroprotection, cognition, prodrug, galantamine

1 user(s) are reading this topic

0 members, 1 guests, 0 anonymous users